- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Ocular Therapeutix Announces Successful Completion of Study of Sustained Drug Delivery Moxifloxacin Punctum Plug

Posted By Dr. Ari Weitzner On October 14, 2010 @ 2:31 am In Cataract,Conjunctivitis,Industry News,Products | Comments Disabled

Ocular Therapeutix, Inc. announced the successful completion of a clinical study of their sustained drug delivery moxifloxacin punctum plug. The study was a single-site, single-armed, single-dose study in which 10 patients received the punctum plug immediately following cataract surgery and were evaluated over a 10-day period.

Primary outcome measures were plug retention and moxifloxacin levels above the minimum concentration to stop growth in various strains of bacterial conjunctivitis.

Click here [1] to read the full press release.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/004574-ocular-therapeutix-announces-successful-completion-of-study-of-sustained-drug-delivery-moxifloxacin-punctum-plug/

URLs in this post:

[1] Click here: http://www.ocutx.com/homepages/37/d181126334/htdocs/images/stories/otx_completes_pop_with_moxifloxacin_puntum_plug.pdf

Copyright © 2008 Eye Doc Talk. All rights reserved.